What’s Next For Merck Stock After An Upbeat Q3?

What’s Next For Merck Stock After An Upbeat Q3?

Following a solid performance in Q3, Merck raised its full year outlook for sales to be in the range of $47.4 billion and $47.9 billion, compared to its earlier estimate of $46.4 billion to $47.4 billion. Looking at the bottom line, the company now expects its adjusted EPS to be in the range of..